Mia's Feed
Medical News & Research

Multisociety Calls for Enhanced Infection Prevention and Control in Healthcare Facilities

Multisociety Calls for Enhanced Infection Prevention and Control in Healthcare Facilities

Share this article

2 min read

A coalition of leading healthcare organizations, including the Society for Healthcare Epidemiology of America (SHEA), the Association for Professionals in Infection Control and Epidemiology (APIC), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS), has issued a comprehensive joint position paper emphasizing the need to strengthen infection prevention and control (IPC) programs within U.S. healthcare facilities. Despite substantial progress over the years in reducing healthcare-associated infections (HAIs), the COVID-19 pandemic highlighted ongoing vulnerabilities and resource gaps in IPC efforts, underscoring the urgent necessity for more robust and well-funded programs.

The position paper advocates for healthcare leaders, regulatory agencies, and payers to treat IPC as a foundational element of healthcare delivery. Dr. Tom Talbot, Past President of SHEA and lead author, emphasized that infection prevention is essential for patient safety, quality care, and operational stability. The document outlines a clear roadmap to transform IPC programs into proactive, effectively resourced entities that can significantly reduce preventable harms.

Key recommendations include prioritizing comprehensive risk management in infection control, establishing direct access of IPC program leaders to senior management for swift support, and incorporating evaluations of leadership and resource allocation into facility surveys by regulatory bodies. The paper criticizes current regulatory standards, such as those from CMS, for lacking precise measures of program effectiveness, which often results in minimum compliance rather than genuine improvement.

To address these issues, the authors propose adopting a dyad leadership model — pairing a Medical Director of IPC with an Infection Preventionist Director of IPC — to foster better communication, collaboration, and strategic planning. They also call for revised standards that promote continuous improvement, data-driven interventions, and measurable outcomes.

Prioritizing effective IPC programs not only enhances patient safety but also offers financial benefits by reducing healthcare costs related to preventable infections. The Society emphasizes that investing in robust IPC infrastructure and leadership is crucial for maintaining trust, improving health outcomes, and ensuring a resilient healthcare system.

Future initiatives will focus on equipping healthcare facilities with the necessary tools and training to implement these best practices, ultimately elevating infection control standards nationwide.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Long-Term Obesity Associated with Accelerated Biological Aging in Young Adults

Persistent obesity in young adults is linked to the early expression of aging biomarkers, indicating accelerated biological aging and potential health risks. A new study highlights the importance of weight management for healthy aging.

Enhancing Mitochondrial Function and Platelet Production through Potassium Regulation

Recent research uncovers how potassium channel KCNN4 influences mitochondrial health and enhances platelet production, offering promising avenues for transfusion medicine and thrombocytopenia treatments.

How Air Pollution Causes Immune Imbalance and Lung Damage: New Research Insights

New research from Pusan National University reveals how long-term air pollution exposure triggers immune imbalance and lung inflammation through oxidative stress and NRF2 pathway activation, worsening respiratory conditions like asthma.

Revolutionary Use of Cancer Medications Enhances Stroke Recovery and Reduces Brain Damage

Research from Singapore reveals that repurposing cancer drugs, HDAC inhibitors, can protect neurons, reduce brain damage, and enhance recovery after stroke by modulating immune cell activity in the brain. This innovative approach offers new hope for extending stroke treatment windows and improving outcomes.